- Home
- Software Solutions
- Resources
- Corporate
Risk of Hepatitis B Reactivation in Patients With Prior HBV Exposure Undergoing Rituximab-containing Chemotherapy: A Prospective Study
Sponsors:
| Phases: | |
| Indications | Acronym: | |
| ||
Age Groups:
| Gender: Both | |
| Names: | Enrollment: 70 | |
Additional information about NCT01502397.